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Background: The factors influencing outcome after Critical Care Unit (CCU) for patients with status epilepticus (SE) 
are poorly understood.   We examined survival for these patients to establish (a) whether the risk of mortality has 
changed over time and (b) whether admission to different unit types affects mortality risk over and above other risk 
factors. 
Methods: We analysed the Intensive Care National Audit & Research Centre (ICNARC) database and the Case Mix 
Programme Database (CMPD) (January 2001 - December 2016). Units were defined as neuro-CCU (NCCU), general 
CCUs with 24-hr neurological support (GCCU-N) or general CCU with limited neurological support (GCCU-L). 
Results: There were 35,595 CCU cases of SE with a threefold increase over time (4,739 in 2001-2004 to 14,166 in 
2013-2016). More recent admissions were older and were more often unsedated on admission. Mortality declined for all 
units though this was more marked for NCCUs (8·1% in 2001-2004 to 4.4% in 2013-2016 compared to 5.1% and 4.1% 
for GCCU-L). Acute hospital mortality was 2-3 times higher than CCU mortality although this has also declined with 
time. GCCU-L appeared to have lower mortality that NCCUs (OR 0.84, 95% CI 0.72, 0.98) but after post-hoc 
adjustment for case mix there were no differences. Older age and markers of morbidity of seriousness were all 
associated with increased mortality risk. 
Conclusions: The number of patients admitted to CCU for SE is rising but critical care and acute hospital mortality is 
decreasing.   Patients treated in NCCU have higher mortality but this is explicable by more severe underlying disease.  
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Introduction and background 
Most patients in the UK with life-threatening neurological conditions are treated on general critical care units (GCCUs), 
where specialist neurological support is limited. Treatment in a specialist Neurocritical Care Unit (NCCU) may improve 
outcomes[1] and reduce length of stay (LOS)[2,3] although this may be confounded by case mix[4]; we demonstrated 
improved survival for intracranial haemorrhage when treated in an NCCU5. 
 
Status epilepticus (SE) causes death or severe disability if untreated [6-8]. Its incidence is estimated between 4·6 [9] to 
41 per 100,000 [10], most often 10 to 20 per 100,000 [11-16]; and has increased over recent decades [15].  
 
Age-standardized mortality for all patients with SE using population-based studies varied from 1·79 per million to 1·89 
per million between 1999 and 2010 [17]. Mean adjusted mortality rate was 2·4 per million in England and Wales with a 
decrease in deaths between 2001 and 2013[18].  Guidelines for managing SE have evolved with improved 
neuromonitoring and new antiepileptic drugs[19-21]. Recent studies show case fatality rates from 8·8% to 10·7% 
[9,15,22], and lower (3·5%) in those admitted with a primary diagnosis of generalized convulsive SE [22]; there are no 
data on CCU mortality rates. 
 
We investigated patterns of admission and outcome for NCCUs and GCCUs in the United Kingdom over the last 15 
years using the United Kingdom’s Intensive Care National Audit & Research Centre (ICNARC) database for adult 
critical care [23]. We examined whether (a) the risk of mortality from SE changed over time and (b) whether admission 
to different unit types is associated with mortality risk.   
 
Methods 
Case Mix Programme Database 
The Case Mix Programme (CMP) is the national clinical audit for adult critical care in England, Wales and Northern 
Ireland. The CMP Database (CMPD) contains pooled case mix, resource use and outcome data on consecutive 
admissions to both general and specialist CCUs. Reasons for admission to critical care are coded using the ICNARC 
Coding Method, specifically designed for this purpose. CMPD has been independently assessed to be of high 
quality,[24], although the database’s quality for SE has not been specifically tested. Support for the collection and use 
 
 
of patient identifiable data without consent has been obtained under Section 251 of the NHS Act 2006 (approval 
number PIAG 2–10(f)/2005).  
 
Selection of patients  
Data were extracted for admissions to CCUs between 1 January 2001 and 31 December 2016. Cases were identified 
where the primary reason for admission to critical care was ‘status epilepticus or uncontrolled seizures’. Admissions 
following elective surgery with a surgical code for SE were excluded (predominantly from one quaternary centre 
performing epilepsy surgery). 
 
Classification of units  
CCUs were grouped into three categories. NCCU were defined as either specialised units treating neurological and 
neurosurgical cases or units in a neurosciences centre with specialised neurocritical care area within a combined unit. 
GCCUs were sub-divided in those with neuroscience support (GCCU-N), units with 7 or more full-time equivalent 
consultant neurologists based at the same trust, which we considered as the minimum number to provide around the 
clock neurology cover; and GCCUs with limited neuroscience support (GCCU-L). 
 
Case mix 
Data were extracted for age, gender, location prior to admission, admission type, Glasgow Coma Score (GCS), sedation 
status and acute severity of illness, assessed with the ICNARC Physiology Score [23] and APACHE II score [25]. Both 
scores encompass a weighting for acute physiology defined by derangement from the normal range for 12 physiological 
variables in the first 24 hours following admission to the CCU. APACHE II additionally weights for age and for severe 
conditions in the past medical history. 
 
Outcome 
Data were extracted for vital status at discharge (dead or alive) from the CCU and at the end of the acute hospital 
episode. Patients transferred from the original hospital to another acute hospital were followed up until final discharge. 
 
Duration of care  
 
 
Data were extracted for LOS in the CCU and in acute hospital as well as location post-discharge from the CCU and 
acute hospital.  
 
Statistical analysis 
Time trends were examined by grouping secular periods into 4 groups (2001-2004, 2005-2008, 2009-2012 and 2013-
2016). Case mix, mortality and episode duration were described per time period for each category of CCU. Categorical 
data were summarised as number and percentage; continuous data as mean with standard deviation (SD) or median with 
interquartile range (IQR). Odds ratios for acute hospital mortality were calculated using multilevel logistic regression 
modelling, adjusting for age, gender, ICNARC Physiology Score, admission type, unit type and a linear time trend, with 
CCU as a random effect [26]. As a post-hoc analysis,  to avoid residual confounding, the multilevel model was 
additionally adjusted for prior CCU admission (not for SE) during the same acute hospital stay, duration of acute 
hospital stay prior to CCU, admission (modelled as the logarithm of the number of days in hospital, truncated at 28 days 
due to skewness) and recording of a secondary reason for admission to the CCU and added to the descriptive tables. 
Patients transferred from another CCU and multiple admissions of the same patient within the same acute hospital stay 
were excluded from the multilevel models to ensure that each patient was included only once and that baseline data 
were from the start of the initial CCU episode. As a sensitivity analysis, the final multilevel model was repeated 
excluding patients with a CCU LOS of less than four calendar days to see if our findings were seen when restricted to 
the sub-group of more severely ill-patients. The analyses were performed using Stata 13.0 (Statacorp LP, TX, USA). 
 
Results 
Of 245 adult CCUs in England, Wales and Northern Ireland participating in the Case Mix Programme during the study 
period, we classified 25 as NCCU, 57 as GCCU-N and 163 as GCCU-L. Between 1 January 2001 and 31 December 
2016, there were in total 1,669,462 admissions to these CCUs, of which, 36,011 (2·2%) had a primary reason for CCU 
admission of ‘status epilepticus or uncontrolled seizures’;  excluding 416 direct from theatre following elective epilepsy 
surgery, the final cohort for analysis consisted of 35,595 admissions. 
 
Table 1 describes the demographics and case mix of admissions over time for NCCU, GCCU-N and GCCU-L, 
respectively.  All unit types showed a marked increase in admissions, and more recent admissions are increasingly 
older. Patients in NCCUs were more likely to have transferred either from another hospital or had previously been an 
 
 
in-patient, including a CCU patient for another reason. Whilst measures of case-mix were fairly similar across units and 
time, patients in GCCU-L were more likely to have been sedated for 24 hours or more.  
 
Table 2 shows that critical care mortality was highest for patients admitted to a NCCU in the first epoch, declined over 
time across all unit types, but more markedly in the NCCUs where it was no greater than in other unit types in the last 
epoch. The CCU LOS was longer for NCCU patients, who were more likely to be transferred to a High Dependency 
Unit.  
 
Acute hospital mortality was 2-3 times higher than critical care mortality.  There was a similar reduction in acute 
hospital mortality with time although it remained highest in the NCCU patients. NCCU patients were more likely to be 
transferred to another acute hospital, presumably the source of initial referral.  
 
After excluding 602 (1·7%) readmissions within the same hospital stay, 856 (2·4%) admissions transferred from 
another CCU (to avoid double counting) and 319 (0·9%) admissions with missing outcomes, 33,818 admissions were 
included in the multilevel logistic regression models (Table 3). Unadjusted acute hospital mortality was lowest for 
admissions to GCCU-L and highest for admissions to NCCU (OR for GCCU-L vs NCCU 0.84, 95% CI 0.72 to 0.98) 
with statistically significant heterogeneity across the three unit types (P = 0·038). Older age, worse ICNARC score on 
admission, admission from the same hospital, prior CCU admission, length of prior hospital stay and reason for 
admission were all associated with increased mortality risk. A more recent secular period was associated with reduced 
odds of mortality (3% decline per year, 95% CI 2 to 4%). After adjustment for potential confounders, acute hospital 
mortality remained highest in NCCU (GCCU-L: OR vs NCCU 0·85, 95% CI 0·73 to 0·98; GCCU-N: OR vs NCCU 
0·82, 95% CI 0·69 to 0·96; P-value for heterogeneity = 0·037).  Post hoc investigation identified that admissions to 
NCCUs tended to have longer prior stays in acute hospital, were more likely to have had a previous CCU admission 
(not for SE) and more likely to have a neurological secondary reason for admission. Adjustment for these additional 
confounders greatly reduced the variation in acute hospital mortality across different unit types (P value for 
heterogeneity=0·51), but the secular effect persisted. 
 
The sensitivity analysis among 13,826 admissions with a CCU LOS of at least four days produced similar results.  
Conclusions 
Overall admission to the CCU 
 
 
This analysis demonstrates an increase in the number of admissions over each period in every group of CCU which 
parallels the increased incidence of SE [15].  There has also been an increase of 4 to 5 years in the mean age of adult 
patients admitted to a CCU for SE. Further, in all groups of CCUs, an increasing proportion of patients were either not 
sedated in the first 24 hours on the CCU, or never sedated or paralysed.  There was a tendency to a shorter LOS prior to 
CCU admission, particularly in the GCCU-L. In all units, patients were admitted with a progressively higher GCS, with 
similar changes in the ICNARC and APACHE data, which reflect general severity of illness. These data indicate 
patients are being admitted earlier and with less severe impairment of consciousness, for instance for monitoring of 
intravenous antiepileptic drug treatment rather than purely for sedation and ventilation, which is reflected in the 
increasing proportion of patients who are never sedated of paralysed. CCUs may be less selective and admit more 
patients at earlier stages of the condition, in addition to the probable overall increase in incidence [15]. This may 
indicate that emergency physicians are more aware of the importance of prompt intensive care treatment [7,20,21]. 
Nevertheless, patients with a prompt response to benzodiazepines in the Emergency Department would not typically be 
admitted to the ICU, so there is a bias towards more severe forms of SE in this cohort. 
 
The excess of male admissions has remained consistent. This may reflect higher incidence of SE for men [27], possibly 
related to a higher prevalence of traumatic brain injury in males. It has been suggested that the in-hospital mortality in 
males is lower [14], but in our results gender did not predict mortality.  
 
Specialist Unit admission 
More patients were admitted to specialist NCCUs from within the same hospital, and more frequently came from 
Neurology and Neurosurgery, indicating the patients were already receiving specialist support, presumably because of 
the severity of their epilepsy or due to an underlying neurological disease. In the GCCU-L, patients were more likely to 
be admitted through the Emergency Department (ED), suggesting these cases develop SE de novo, or have been 
previously managed in the community. Thus, it is probable that patients in the NCCU have more severe forms of 
epilepsy or an underlying neurological disease. 
There were increasing planned transfers to the specialist units, suggesting intensivists in general units increasingly refer 
SE to specialised units.  Supporting this, specialist units in our sample had more recurrent admissions, consistent with a 
distinct case mix for NCCUs and GCCU-Ns of more patients with severe epilepsy who are more liable to develop 
recurrent SE and may include a larger proportion of cases whose prognosis is worse. The comparison of mortality will 




Mortality and outcomes 
There was a low mortality rate in all types of CCUs. The high percentage of ventilated patients argues against it being 
due to a selection bias toward less unwell patients. The overall mortality data is comparable with other authors for SE in 
the literature [13,16,28,29,31].  This is an encouraging finding regarding the quality of CCU care for SE in the UK, 
however, the mortality rates in the literature vary significantly depending on the cohort and on whether ICU mortality, 
in-hospital mortality or 1 year mortality is taken, and overall comparisons are difficult. We were interested to note that 
overall mortality does not prove a benefit for NCCU versus GCCU-L admission. Whether or not specialist units per se 
confer a survival advantage, is a matter of ongoing debate, and a database would need to provide more information on 
the severity of illness to answer this question.  
We are however concerned about the much higher acute hospital mortality than expected from the CCU mortality in 
this cohort, which is not restricted to the most severe forms of SE. This is similar to the pattern that we saw in a 
previous study [5]. Few patients are discharged from CCU in a terminal or palliative state and most deaths would be 
expected to take place either on the CCU, or after hospital discharge and featuring as 1 year mortality. We did not have 
cause of death so it is possible that these deaths are related to co-morbidity. Alternatively, it is possible that patients 
with recurrent SE may be refused readmission due to perceived futility. We consider that most patients with recurrent 
SE would re-admitted to CCU and death from epilepsy should be uncommon on general hospital wards.  The results 
indicate that the quality of step down and ward care require further scrutiny. The excess mortality after discharge to the 
ward in our previous study also applied particularly to non-surgical neurological conditions (Guillain Barre Syndrome, 
Myasthenia Gravis) whereas for a “surgical” condition such as intracerebral haemorrhage or traumatic brain injury, 
despite comparable overall CCU mortality and severity, carry a much lower rate of deaths after stepdown [26]. Issues 
that may affect survival after stepdown from CCU include the expertise of ward staff in managing patients with 
aspiration risk, tracheotomy related complications, dysautonomia, reduced awareness, and the availability of specialist 
neurorehabilitation. These results raise the question of whether the pathways of step down in non-surgical patients 
increase risk of death. If so, there is an urgent need for better education of staff and introduction of protocol driven care 
for all neurological patients, comparable with trauma and stroke pathways. These data underline the importance of 
establishing the cause of death in patients who die in hospital after discharge from CCU, monitoring mortality rates, and 




A number of factors limit our conclusions. Firstly, this is a retrospective analysis of an intensive care database, and a 
prospective analysis using a case-control design would allow stronger comparisons between outcomes from different 
unit types. Furthermore, data from a general ICU database have limitations regarding specific diagnoses. We do not 
have access to the specific semiology of SE, which is important for estimating prognosis, and we do not have the exact 
cause of death.  Furthermore, we do not know if our patients with SE had previous epilepsy and if so, the severity.  The 
outcome for patients with known epilepsy who develop SE may differ from that in patients with general neurology or 
medical causes (including drug intoxication, encephalitis, trauma). We do not know the destination of all the patients 
after discharge from the CCU, and may be missing deaths of patients who are not readmitted to the CCU, although we 
believe the number is small. Also,  we lack of data on the exact treatment used. Finally, we do not have precise 
information on the access of the contributing units to procedures such as continuous EEG. Our experience suggests that 
continuous EEG is  available in a very limited number of units, and particularly 10 or more years ago will have been 
used in only a very limited number of cases.   
 
However, even despite these limitations, important practical conclusion are possible. There are still significant 
differences in the practice and the provision of care for SE, despite better understanding of super-refractory SE and 
detailed management protocols,[8,21,30,31]. The outcome for patients with SE should continue to improve with 
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